Keywords: fda, cox-2, recommendations, benefit, bextra, celebex, recent

FDA's COX-2 recommendations "will benefit Bextra and Celebex"

Article | 04 April 2005

• Print This

The recent US Food and Drug Administration advisory committee recommendations for the COX-2 inhibitor drugs are likely to lead to ...

Enjoying this article? To continue reading you need to login or subscribe.